Mexican Scientists Develop Hybrid Chayote Fruit To Battle Cancer
Mexican scientists have developed a hybrid chayote fruit which helps you to battle cancer. The fruit is as effective as Cytarabine, which is used as a medication in treating some types of cancer in order to limit the growth of some cells.
Hybrid chayote fruit is developed by mexican scientists to battle cancer
- Hybrid chayote fruit is made from two wild mexican species
- Cytarabine is a medication used to treat some types of cancer
- Cytarabine controls the growth of malignant cells
According to Santiago Osorio, the raw extract of the hybrid created in his laboratory is 1,000 times as strong as that of regular chayote fruits, which is why he is seeking to launch a business that would put the active substance of this super-chayote on the market.
"One would have to eat many kilos of regular chayote to have the same effect as the hybrid. In any case, it is very healthy to eat this Cucurbitaceae. In fact, many hospitals have included chayote fruits on their menus," he said.
This line of research, according to the statement, was conceived in 2005 as part of efforts by agronomists to discover the possible medicinal benefits of chayote fruits.
According to figures from the World Health Organisation, cancer is the second cause of death in the world, killing nearly 9 million people a year.
In Mexico, where cancer is the third cause of death, 195,925 new cases were reported in 2013, killing 84,172 people in that same year.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
DoctorNDTV is the one stop site for all your health needs providing the most credible health information, health news and tips with expert advice on healthy living, diet plans, informative videos etc. You can get the most relevant and accurate info you need about health problems like diabetes, cancer, pregnancy, HIV and AIDS, weight loss and many other lifestyle diseases. We have a panel of over 350 experts who help us develop content by giving their valuable inputs and bringing to us the latest in the world of healthcare.